Insider Transactions in Q3 2022 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
3,428
-60.17%
|
$2,392,744
$698.0 P/Share
|
Sep 30
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,428
+37.57%
|
$1,415,764
$413.33 P/Share
|
Sep 29
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
3,798
-7.63%
|
$2,635,812
$694.51 P/Share
|
Sep 29
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,798
+38.5%
|
$1,568,574
$413.33 P/Share
|
Sep 12
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
4,696
-1.01%
|
$3,362,336
$716.05 P/Share
|
Sep 09
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
35,304
-50.02%
|
$25,771,920
$730.96 P/Share
|
Sep 09
2022
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+36.17%
|
$22,200,000
$555.67 P/Share
|
Sep 09
2022
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
20,730
-49.86%
|
$15,132,900
$730.96 P/Share
|
Sep 09
2022
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+41.91%
|
$8,100,000
$270.43 P/Share
|
Sep 09
2022
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
609
-36.01%
|
$451,269
$741.0 P/Share
|
Sep 09
2022
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
609
+26.48%
|
$228,984
$376.69 P/Share
|
Sep 08
2022
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
2,558
-54.17%
|
$1,777,810
$695.99 P/Share
|
Sep 08
2022
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,558
+35.14%
|
$1,000,178
$391.92 P/Share
|
Sep 06
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$58,200
$582.03 P/Share
|
Sep 06
2022
|
N Anthony Coles Director |
SELL
Open market or private sale
|
Direct |
6,000
-18.24%
|
$3,480,000
$580.45 P/Share
|
Sep 06
2022
|
N Anthony Coles Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+37.94%
|
$2,232,000
$372.76 P/Share
|
Sep 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$634,700
$577.62 P/Share
|
Sep 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$376,200
$342.93 P/Share
|
Aug 16
2022
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
3,513
-0.53%
|
$2,262,372
$644.61 P/Share
|
Aug 15
2022
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
6,487
-9.47%
|
$4,112,758
$634.25 P/Share
|
Aug 15
2022
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.74%
|
$1,790,000
$179.13 P/Share
|
Aug 09
2022
|
Christine A Poon Director |
SELL
Open market or private sale
|
Direct |
15,000
-60.89%
|
$9,300,000
$620.87 P/Share
|
Aug 09
2022
|
Christine A Poon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+47.06%
|
$2,655,000
$177.82 P/Share
|
Aug 05
2022
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
23,782
-2.28%
|
$14,578,366
$613.95 P/Share
|
Aug 04
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
10,453
-15.31%
|
$6,491,313
$621.48 P/Share
|
Aug 04
2022
|
Arthur F Ryan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,453
+13.34%
|
$4,306,636
$412.58 P/Share
|
Aug 04
2022
|
Arthur F Ryan Director |
SELL
Bona fide gift
|
Direct |
2,500
-11.27%
|
-
|
Aug 04
2022
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
71,218
-48.19%
|
$43,656,634
$613.0 P/Share
|
Aug 04
2022
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
95,000
+39.13%
|
$25,650,000
$270.43 P/Share
|
Aug 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$639,100
$581.53 P/Share
|
Aug 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$376,200
$342.93 P/Share
|
Jul 05
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
357
-0.28%
|
-
|
Jul 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.3%
|
$645,700
$587.76 P/Share
|
Jul 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+5.04%
|
$376,200
$342.93 P/Share
|